NORMAL SITUATION

Medical,Equipement,Devices & Oncology Consultancy

Export PDF

Company — Normal situation.

Financial year 2024 · Closed on 30/09/2024

Net result18,6 k €-25,4 %over 1 year

Gross margin8,6 k €-36,2 %over 1 year

Equity613,6 k €+3,1 %over 1 year

Identity

Source · BCE/KBO

Medical,Equipement,Devices & Oncology Consultancy is a company registered in Belgium.

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0424.618.983
Legal form: Public limited company
Contributed capital: 555 070,62 €
Latest accounts: 30/09/2024

Signals

ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 38 filings

Trend over 17 financial years

	2024		2023		2022		2021		2020
Income statement
Gross margin	8,6 k €	-36.2%	13,5 k €	+350%	-5,4 k €	-104%	137,2 k €	-30.4%	197,2 k €
EBITDA	8,1 k €	-37.9%	13,1 k €	+322%	-5,9 k €	-104%	136,6 k €	-30.7%	197,1 k €
Operating result	8,1 k €	-37.9%	13,1 k €	+322%	-5,9 k €	-104%	136,6 k €	-30.7%	197,1 k €
Net result	18,6 k €	-25.4%	24,9 k €	+171%	9,2 k €	-92.0%	115,2 k €	-33.3%	172,6 k €
Balance sheet
Equity	613,6 k €	+3.1%	595 k €	+4.4%	570,1 k €	+1.6%	560,9 k €	+25.8%	445,7 k €
Total assets	621,3 k €	+2.8%	604,3 k €	+5.8%	571 k €	-6.3%	609,6 k €	+22.8%	496,4 k €
Cash	20,7 k €	-57.0%	48,2 k €	+41.9%	33,9 k €	+1293%	2,4 k €	+24.5%	2 k €
Debts	7,7 k €	-16.9%	9,3 k €	+973%	867,3 €	-98.2%	48,6 k €	-4.1%	50,7 k €

Board of directors

Source · NBB, accounts to 30/09/2024

2 active · 15 ended

Active mandates

Jozef Van Dam

Managing director · since 20 mars 2020 · until 20 mars 2026

Active

Kriztina Kovacs

Director · since 20 mars 2020 · until 20 mars 2026

Active

Ended mandates

Krisztina Kovacs

Director · since 20 mars 2020 · until 20 mars 2026

Ended

Christel Clara Remigius Verboven

Director · since 29 janvier 2014 · until 20 mars 2020

Ended

David Lowry Ergun

Director · since 29 janvier 2014 · until 20 mars 2020

Ended

Jozef Van Dam

Managing director · since 29 janvier 2014 · until 20 mars 2020

Ended

Full financial information

Source · NBB

	2024	2023	2022	2021	2020	2019
Type of account	Micro model	Micro model	Micro model	Micro model	Micro model	Micro model
Start of the financial year	01/10/2023	01/10/2022	01/10/2021	01/10/2020	01/10/2019	01/10/2018
Closing of the financial year	30/09/2024	30/09/2023	30/09/2022	30/09/2021	30/09/2020	30/09/2019
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	28/03/2025	04/04/2024	26/04/2023	23/03/2022	04/05/2021	29/04/2020
General meeting	21/03/2025	15/03/2024	17/03/2023	18/03/2022	19/03/2021	20/03/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 38 filings

Model	Closing	General meeting	Filed	Language	Document
Micro model	30/09/2024	21/03/2025	28/03/2025	Dutch	PDF
Micro model	30/09/2023	15/03/2024	04/04/2024	Dutch	PDF
Micro model	30/09/2022	17/03/2023	26/04/2023	Dutch	PDF
Micro model	30/09/2021	18/03/2022	23/03/2022	Dutch	PDF
Micro model	30/09/2020	19/03/2021	04/05/2021	Dutch	PDF
Micro model	30/09/2019	20/03/2020	29/04/2020	Dutch	PDF
Micro model	30/09/2018	15/03/2019	30/04/2019	Dutch	PDF
Micro model	30/09/2017	16/03/2018	29/03/2018	Dutch	PDF
Abridged model	30/09/2016	17/03/2017	05/04/2017	Dutch	PDF
Abridged model	30/09/2015	18/03/2016	22/03/2016	Dutch	PDF
Abridged model	30/09/2014	24/03/2015	25/03/2015	Dutch	PDF
Abridged model	30/09/2013	30/01/2014	19/02/2014	Dutch	PDF
Abridged model	31/12/2011	05/06/2012	09/08/2012	Dutch	PDF
Abridged model	31/12/2010	07/06/2011	04/08/2011	Dutch	PDF
Abridged model	31/12/2009	01/06/2010	03/06/2010	Dutch	PDF
Abridged model	31/12/2008	23/06/2009	22/07/2009	Dutch	PDF
Abridged model	31/12/2007	24/06/2008	10/07/2008	Dutch	PDF
Abridged model	31/12/2006	12/06/2007	14/06/2007	Dutch	PDF
Abridged model	31/12/2005	06/06/2006	07/06/2006	Dutch	PDF
Abridged model	31/12/2004	07/06/2005	28/07/2005	Dutch	PDF
Abridged model	31/12/2003	01/06/2004	31/12/2004	Dutch	PDF
Abridged model	31/12/2002	03/06/2003	15/06/2005	Dutch	PDF
Abridged model	31/12/2001	04/06/2002	15/06/2005	Dutch	PDF
Abridged model	31/12/2000	05/06/2001	26/08/2002	French	PDF

View all 38 filings

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 30/09/2024

2 active · 15 ended

Active mandates

Jozef Van Dam

Managing director · since 20 mars 2020 · until 20 mars 2026

Active

Kriztina Kovacs

Director · since 20 mars 2020 · until 20 mars 2026

Active

Ended mandates

Krisztina Kovacs

Director · since 20 mars 2020 · until 20 mars 2026

Ended

Christel Clara Remigius Verboven

Director · since 29 janvier 2014 · until 20 mars 2020

Ended

David Lowry Ergun

Director · since 29 janvier 2014 · until 20 mars 2020

Ended

Jozef Van Dam

Managing director · since 29 janvier 2014 · until 20 mars 2020

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Dissolution03/11/2025
RUBRIEK EINDE (STOPZETTING, INTREKKING STOPZETTING, NIETIGHEID, GER. AK., GERECHTELIJKE REORGANISATIE, ENZ... - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Restructuring30/07/2025
RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Mandates31/12/2020
MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
PDF
Mandates30/12/2015
ONTSLAGEN - BENOEMINGEN
PDF
Registered office19/10/2015
MAATSCHAPPELIJKE ZETEL
PDF
Mandates18/09/2015
ONTSLAGEN - BENOEMINGEN
PDF
Mandates10/11/2014
ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares31/03/2014
KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2024
Annual accounts 202418,6 k €↓
2023
Annual accounts 202324,9 k €↑
2022
Annual accounts 20229,2 k €↓
2021
Annual accounts 2021115,2 k €↓
2020
Annual accounts 2020172,6 k €↑
2019
Annual accounts 2019143,7 k €↑
2018
Annual accounts 2018138,5 k €↑
2017
Annual accounts 201748,6 k €↑
2015
Annual accounts 2015-17,3 k €↑
2014
Annual accounts 2014-30 k €↓
2013
Annual accounts 2013-3,2 k €↓
2011
Annual accounts 2011255,5 €↑
2010
Annual accounts 2010-2,3 k €↓
2009
Annual accounts 2009-600,5 €↓
2008
Annual accounts 20085,2 k €↑
2007
Annual accounts 2007-11,3 k €↑
2006
Annual accounts 2006-19,8 k €

Medical,Equipement,Devices & Oncology Consultancy

Overview

Identity

Financials

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline